There is no known pharmacological interaction from same-day administration
C., DiMarchi, R
Harpreet Singh Bajaj, MD, MPH, an endocrinologist at LMC Diabetes & Endocrinology in Toronto, Canada, will present the primary results of the first phase 3 study of retatrutide in patients with type 2 diabetes, the TRANSCEND-T2D-1 trial
Ice after injection for 5 minutes
However, people taking these medicines must be watched closely because of uncommon, but serious adverse reactions: Infections from bacteria, viruses, and fungi Skin cancer, but not melanoma Skin reactions Allergic reactions Worsened heart failure Damage to nerves Low white blood cell count SURGERY Surgery may be needed to correct severely damaged joints
Many people may require ongoing treatment to maintain results